Author

I. Armandari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

E. H. Hoving· 1 shared F. J. G. Scherpen· 1 shared G. de Haan· 1 shared I. Bockaj· 1 shared J. T. M. L. Paridaen· 1 shared M. H. Schoots· 1 shared M. J. Smit· 1 shared M. Ritsema· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. H. Hoving

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The developmental stage of the medulloblastoma cell-of-origin restricts Hedgehog pathway usage and drug sensitivity

M. J. Smit, I. Armandari, I. Bockaj, T. E. I. Martini, W. W. Zomerman, Z. Siragna, T. G. J. Meeuwsen-de Boer, F. J. G. Scherpen, M. H. Schoots, M. Ritsema, W. F. A. den Dunnen, E. H. Hoving, J. T. M. L. Paridaen, G. de Haan, V. Guryev, S. Bruggeman

The paper shows that the developmental stage of medulloblastoma cell-of-origin affects Hedgehog pathway usage and drug sensitivity, with downstream pathway targets being more effective in infant patients.

bioRxiv · Jan 22, 2021Cancer Biology